Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

SSXB1 Inhibitors

SSXB1 inhibitors are a class of chemical compounds designed to selectively interact with a specific biological target known as SSXB1, a protein or enzyme that plays a role in a particular biological process within cells. The exact nature and function of SSXB1 are elucidated through extensive biochemical and molecular biology research, which reveals its involvement in a cellular pathway or process. The inhibitors are crafted through a detailed understanding of the structure and mechanism of action of SSXB1, allowing for the design of molecules that can bind to the active site or another critical region of the protein, thus modulating its activity. The process of developing an SSXB1 inhibitor involves the use of various technologies, including computational modeling, medicinal chemistry, and high-throughput screening, to identify compounds that have the desired interaction with SSXB1.

Inhibitors, like those targeting SSXB1, are typically characterized by their specificity and affinity for their intended target. Specificity refers to the ability of the inhibitor to interact with SSXB1 as opposed to other proteins, which is crucial for the modulation of the particular biological process without affecting others. Affinity, on the other hand, measures the strength of the interaction between the inhibitor and SSXB1. Higher affinity compounds are often more desirable as they require lower concentrations to achieve the modulation of the target protein. The design of SSXB1 inhibitors also considers the compound's stability, solubility, and cell permeability, to ensure that it can reach and maintain effective concentrations at the site of action within the cell. Researchers use a combination of experimental assays and predictive models to refine the inhibitors' properties, balancing these factors to optimize the interaction with SSXB1.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GSK 690693

937174-76-0sc-363280
sc-363280A
10 mg
50 mg
$255.00
$1071.00
4
(1)

GSK690693 is an Akt inhibitor that would prevent the activation of Akt-dependent signaling pathways. If SSXB1 is an Akt substrate or is regulated by Akt signaling, then GSK690693 would indirecty inhibit SSXB1 activity.

AZD8055

1009298-09-2sc-364424
sc-364424A
10 mg
50 mg
$163.00
$352.00
12
(2)

AZD8055 is a potent ATP-competitive inhibitor of mTOR kinase, affecting both mTORC1 and mTORC2 complexes. SSXB1, if regulated by mTOR pathways, would have reduced activity due to inhibition by AZD8055.